期刊文献+

林州市贲门癌P53和PCNA与癌旁肠上皮化生的关系 被引量:1

P53 and proliferating cell nuclear antigen in patients with gastric cardiac adenocarcinoma with and without paracancerous intestinal metaplasia in Linzhou city
下载PDF
导出
摘要 目的:探讨贲门腺癌(gastric cardia adeno- carcinoma,GCA)的P53和PCNA分子学特征与癌旁肠上皮化生(intestinal metaplasia,IM)的关系.方法:采用ABC免疫组织化学分析(immuno- histochemistry,IHC)法研究了70例癌旁含IM和不含IM的贲门癌P53和PCNA蛋白表达变化的特征.结果:癌旁含IM的GCA中P53蛋白阳性高表达率明显高于癌旁不含IM的GCA(33.33% vs 4.65%,P<0.01),而PCNA蛋白在两组中的阳性高表达率(74.07%和79.07%)比较无显著性差异(P>0.05).结论:癌旁含IM和不含IM的GCA形态相似,但可能具有不同的分子基础. AIM: To characterize the expression of P53 and proliferating cell nuclear antigen (PCNA) proteins in gastric cardiac adenocarcinoma (GCA) with and without paracancerous intestinal metaplasia (IM).METHODS: Immunohistochemical analysis (ABC method) was performed on tissues re- sected from 70 cases of GCA with and without paracancerous IM.RESULTS: The high positive expression rate for P53 protein in GCA tissues with paracancerous IM (33.33%) was significantly higher than that in GCA tissues without paracancerous IM (4.65%) (P 〈 0.01), and the high positive expression rate for PCNA protein did not significantly differ be- tween the two groups (74.07% and 79.07%).CONCLUSION: The high positive expression rate for P53 protein in GCA with paracancerous IM is significantly higher than without paracan- cerous IM, suggesting the possibility of a dif- ferent molecular basis in the two types of GCA with similar morphology.
出处 《世界华人消化杂志》 CAS 北大核心 2007年第31期3343-3346,共4页 World Chinese Journal of Digestology
基金 国家杰出青年科学基金 No.30025016 国家自然科学基金 No.30670956 河南省医学科技创新人才工程基金 No.20040055 河南省自然科学基金 No.0511043200 河南省食管癌重点开放实验室开放基金 No.20050227
关键词 P53 细胞增殖核抗原 贲门癌 肠上皮化 生免疫组化 P53 Proliferating cell nuclear antigen Gastric cardiac adenocarcinoma Intestinal metapla-sia Immunohistochemistry
  • 相关文献

参考文献22

二级参考文献71

共引文献93

同被引文献13

  • 1陈曦,范宗民,蔺红丽,崔纪丽,刘亚丽,陈莉莎,宋昕,王苒,李贝,黄浦慧,王立东.贲门癌瘤体最长直径与临床病理特征的关系及其对患者生存期的影响[J].肿瘤防治研究,2014,41(3):209-213. 被引量:5
  • 2MIN SU, MIN LIU, DONG - PING TIAN,et al. Temporal trends of esophageal cancer during 1995 -2004 in Nanao Island, an ex- tremely high - risk area in China [ J ]. Eur J Epidemiol, 2007,22 (1) :43 -48.
  • 3CHIH - HUNG LIN, CHIA - HSING LIU, CHIEN - HUI WEN, et al. Differential CD133 expression distinguishes malignant from be- nign papillary lesions of the breast[ J]. Virchows Arch, 2015,466 (2) :177 -184.
  • 4TAI W, MAHATO R, CHENG K. The role of HER2 in cancer therapy and targeted drug delivery [ J ]. J Control Release, 2010, 146(3) :264 -275.
  • 5ARAUJO A, RIBEIRO R, AZEVEDO I, et al. Genetic polymar- phisms of the epidermal growth factor and related ~ceptor in non - small cell lung cancer- a review of the literature[ J]. The oncolo- gist, 2007, 12(2) : 201 -210.
  • 6陈娟,李东石,余英豪,等.HER-2蛋白在胃癌中的表达及其l临床意义[J].世界华人消化杂志,2010,18(13):1375-1379.
  • 7SIMSEK H, HAN l J, ONA B, et al. The expression of EGFR, eerbB2, p16, and p53 and their relationship with conventional pa- rameters in squamous cell eareinoma of the larynx[ J~]. Turk .~ Med Sci,2014,44(3) :411 -416.
  • 8SASTRE -GARAU X, GENIN P, ROUSSEAU A, et al. Increased cell size and Akt activation in HER - 2/neu - overexpressing inva- sire ductal carcinoma of the breast[J]. Histopathology, 2004,45 (2) :142 -147.
  • 9CANGIR A K, KUTLAY H, AKAL M, et al. Prognostic value of tumor size in non - small cell lung cancer larger than five centime- ters in diameter[ J ]. Lung Cancer,2004,46 ( 3 ) :325 - 331.
  • 10KATO T, TAKASHIMA A, KASAMATSU T, et al. Clinical tumor diameter and prognosis of patients with F1GO stage IB1 cervical cancer (JCOG0806 -A) [J]. Gynecol Oncol,2015,137( 1 ) :34 -39.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部